Real-world outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of large B-cell lymphoma (LBCL): Impact of age and specific organ dysfunction Meeting Abstract
| Authors: | Locke, F. L.; Jacobson, C.; Ma, L.; Dong, H.; Hu, Z. H.; Siddiqi, T.; Ahmed, S.; Ghobad, A.; Miklos, D. B.; Lin, Y.; Perales, M. A.; Lunning, M. A.; Herr, M. M.; Hill, B. T.; Ganguly, S.; Mirza, A. S.; Nikiforow, S.; Xu, H.; Pasquini, M. C. |
| Abstract Title: | Real-world outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of large B-cell lymphoma (LBCL): Impact of age and specific organ dysfunction |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398802072 |
| DOI: | 10.1182/blood-2021-149679 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 530 -- Hybrid meeting, also took place online -- -- Source: Wos |
